BRCA1 mutations are linked preferentially to the triple negative form of BC (estrogen receptor negative, progesterone receptor negative, and HER2 negative, TNBC), whereas BRCA2-associated breast cancers are generally estrogen receptor-positive [6], and phenotypically different (mostly luminal-like BC) [7]. This evidence concerns the gene ERBB2 and breast cancer.